Oncology
www.springworkstx.com
HBM contact: Dr Ivo Staijen
Company status: public
SpringWorks Therapeutics is a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer.
© HBM Partners AG | Bundesplatz 1 | 6300 Zug, Switzerland | Phone +41 43 888 7171